Moreover, olaparib-based combination therapy suppressed the formation of Rad51 foci and induced a growth stabilization of BCSphCs and TNBC BRCAmut tumor xenografts, which lacked regrowth after treatment suspension (Fig. 4K and Supplementary Fig. S4S, T). This evidence concerns the gene RAD51 and neoplasm.